1.

Emergence of PER and VEB extended-spectrum -lactamases in Acinetobacter baumannii in Belgium

1.

Emergence of PER and VEB extended-spectrum {beta}-lactamases in Acinetobacter baumannii in Belgium

2.

Emergence of PER and VEB extended-spectrum {beta}-lactamases in Acinetobacter baumannii in Belgium

3.

Emergence of PER and VEB extended-spectrum {beta}-lactamases in Acinetobacter baumannii in Belgium

1.

Genetic Structure associated with blaOXA-18 Gene, Encoding a Clavulanic-Acid Inhibited Extended-Spectrum Oxacillinase.

2.

Genetic Structure associated with blaOXA-18 Gene, Encoding a Clavulanic-Acid Inhibited Extended-Spectrum Oxacillinase.

3.

Genetic Structure associated with blaOXA-18 Gene, Encoding a Clavulanic-Acid Inhibited Extended-Spectrum Oxacillinase.

1.

Plasmid-Encoded Carbapenem-Hydrolyzing β-Lactamase OXA-48 in an Imipenem-Susceptible Klebsiella pneumoniae Strain from Belgium

1.

Silent spread of IMP-13-producing Pseudomonas aeruginosa belonging to sequence type 621 in Belgium

2.

Silent spread of IMP-13-producing Pseudomonas aeruginosa belonging to sequence type 621 in Belgium

3.

Silent spread of IMP-13-producing Pseudomonas aeruginosa belonging to sequence type 621 in Belgium

4.

Silent spread of IMP-13-producing Pseudomonas aeruginosa belonging to sequence type 621 in Belgium

5.

Silent spread of IMP-13-producing Pseudomonas aeruginosa belonging to sequence type 621 in Belgium

1.

Carbapenem-Resistant Acinetobacter baumannii Isolates Expressing the bla OXA-23 Gene Associated with IS Aba4 in Belgium

1.

In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium

2.

In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium

3.

In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium

1.

In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium.

2.

In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium.

3.

In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium.

1.

Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium.

2.

Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium.

3.

Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium.

4.

Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium.

5.

Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium.

6.

Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium.

7.

Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium.

1.

GES extended spectrum beta-lactamases in Acinetobacter baumannii in Belgium.

2.

GES extended spectrum beta-lactamases in Acinetobacter baumannii in Belgium.

3.

GES extended spectrum beta-lactamases in Acinetobacter baumannii in Belgium.

4.

GES extended spectrum beta-lactamases in Acinetobacter baumannii in Belgium.

5.

GES extended spectrum beta-lactamases in Acinetobacter baumannii in Belgium.

6.

GES extended spectrum beta-lactamases in Acinetobacter baumannii in Belgium.

7.

GES extended spectrum beta-lactamases in Acinetobacter baumannii in Belgium.